Patricia J. Armati

Prof. Patricia J. Armati

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
PAPatricia J. Armati
Patricia J. Armati
EMEmily K. Mathey
Emily K. Mathey

6 March 2014 in Journal of the Peripheral Nervous System
Verified
Journal Article
Closed access
PDF file
PAPatricia J. Armati
Patricia J. Armati
EMEmily K. Mathey
Emily K. Mathey

16 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
RCRoberta Therese Chow
Roberta Therese Chow
PAPatricia J. Armati
Patricia J. Armati
The use of light (photons) delivered clinically from laser or light-emitting diodes (LED), is referred to as photobiomodulation therapy (PBMt). Increasingly PBMt is accepted particularly in dental practice for pain or pre-emptive anaesthesia. Understanding its mechanism of effectiveness is the key to its increasing acceptance. Of major importance to this is how PBMt affects not only the neurons but also the Schwann cells and fibroblasts of the peripheral nervous system which are unique in morphology and function. The specific roles of the neuronal cells of the dorsal root and trigeminal ganglia, now include consideration of the axon initial segment responsible for the initiation of the action potential and the T junction from which the distal and proximal axons arise which are complex but central to normal function. This cellular complexity, organization and function is discussed leading to a review of the mechanism of effectiveness of PBMt demonstrated by clinical trials in both medicine and dentistry. This review provides evidence of the involvement of the cytoskeleton, mitochondrial organization particularly related to fast and slow axonal flow and mitochondrial membrane potential in response to light in somatosensory neurons and nerves.

21 October 2010
Verified
Book Chapter
Closed access
EMEmily K. Mathey
Emily K. Mathey
AAAriel Arthur
Ariel Arthur
PAPatricia J. Armati
Patricia J. Armati
If one desired to throw new light on the effect of disease, or injury, and of the process of healing in the brain, the best hope lay in the study of the non-nervous cells. No Man Alone, Wilder Penfield, 1977 (Gill and Binder, 2007) NEUROGLIA For the past 160 or so years the cells of the nervous system have been divided into two main categories: neurons and glia (Kettenmann and Verkhratsky, 2008). Prior to this, ever since the first image of a neuron was published in 1836 by Gabriel Valentin, the nerve cell had been in a class of its own (Lopez-Munoz et al., 2006). Some 20 years later in 1856 the term neuroglia was introduced by the German physician Rudolph Virchow. Virchow, also known as the “Pope of pathology” (Kettenmann and Ransom, 2005; Magner, 2002), described a “connective substance … in which nervous system elements are embedded” and referred to it as “nervenkitt” (or nerve putty). This description led to the use of the term “neuroglia,” which derives from archaic Greek, meaning something sticky or clammy. The notion that neuroglia were there merely as neural putty was treated with the reverence usually reserved for a bona fide papal encyclical and as such neuroglia remained sidelined for decades to come. Even though Virchow was responsible for the term neuroglia coming into use, at this stage he did not recognize that it was made up of cells rather than an acellular connective tissue.

Verified
Journal Article
Open access
PDF file
RCRoberta Therese Chow
Roberta Therese Chow
PAPatricia J. Armati
Patricia J. Armati
This review aims to provide a translational link between clinical evidence in the application of photobiomodulation for treatment of painful conditions in medicine and dentistry and neurophysiological effects of photobiomodulation therapy (PBMt). PBMt is gaining increasing acceptance as a therapeutic modality for pain management, particularly within dental practice. However, a clearer understanding of its mechanisms of action remains essential for broader clinical adoption and integration into mainstream healthcare. Central to the therapeutic effects of PBMt for pain is its interaction with neurons, which possess unique structural and functional characteristics. Advances in our understanding of the cellular architecture of dorsal root and trigeminal ganglion neurons highlight the importance of the stem axon and axon initial segment (AIS), a specialized region adjacent to the axon hillock that is now recognized as the principal site of action potential initiation. These developments have important implications for understanding the biological effects of PBMt and its clinical application. This review synthesizes evidence demonstrating that PBM influences cytoskeletal organization, mitochondrial structure and function, and intracellular signaling pathways, with downstream effects on neuronal excitability and nerve conduction. By integrating findings from cellular, neurophysiological, and clinical studies, the review examines how these mechanistic effects may contribute to pain modulation and analgesia.